INSIGHTS ON ENTERPRISE SOLUTIONS

• Benefits Of Isolator Technology In Fill-Finish

  Isolator technology enhances sterility assurance, reduces contamination risk, improves operator safety, and supports regulatory compliance, making it essential for modern aseptic fill-finish operations.

• MES Apps Built For Speed And Seamless Integration

  Digitize bioprocess workflows to achieve consistent, paper-free execution that deploys up to 66% quicker than traditional MES with a cloud-based, no-code platform built for single-use bioprocessing.

• Eliminate Risk From Your Viral Vector Tech Transfers

  Explore strategies to simplify viral vector tech transfers, reduce risk, and maintain quality under tight timelines, as well as a case study that demonstrates how to streamline this critical process.

• Navigating Regulatory Expectations For Injectable Packaging

  Explore insights on extractables, focusing on how they relate to the revised EU GMP Annex 1, new and evolved expectations under USP <382>, and the use of VHP decontamination in aseptic environments.

• CDMO Media And Buffer Outsourcing: A Strategic Advantage

  12/4/2025

  Learn how outsourcing cell culture media and buffers removes bottlenecks, freeing specialized CDMO resources. Ensure consistency, accelerate timelines, and streamline GMP readiness for client success.

• Critical Path For Gene Therapy: AAV Analytical Lifecycle Considerations

  12/2/2025

  Explore considerations for phase-appropriate AAV characterization and release activities from pre-clinical to late-phase products. Review validation challenges and paths for maturation of analytics.

• Raising The Bar In Gene Therapy

  12/1/2025

  Learn how a science-driven and digitally structured approach reduced onboarding timelines for gene therapy from 12 months to just 3, setting a new benchmark in technology transfers.

• Framework To Deliver Standardized, Reliable Biomanufacturing Facilities

  11/25/2025

  Standardized, continuously optimized facility design enables scalable, efficient, and reliable biomanufacturing that improves quality, accelerates timelines, and ensures consistent performance across sites.